Atara Biotherap
(ATRA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 128,940 | 8,573 | 63,573 | 20,340 | 0 |
| Cost of Goods | 21,009 | 8,886 | N/A | N/A | N/A |
| Gross Profit | 107,931 | -313 | 63,573 | 20,340 | N/A |
| Operating Expenses | 191,378 | 276,579 | 344,086 | 360,802 | 309,052 |
| Operating Income | -83,438 | -276,006 | -280,513 | -340,462 | -309,052 |
| Interest Expense | 4,615 | 5,285 | 373 | 0 | 0 |
| Other Income | 2,638 | 5,180 | 52,596 | 367 | 2,447 |
| Pre-tax Income | -85,415 | -276,111 | -228,290 | -340,095 | -306,605 |
| Income Tax | -12 | 15 | 12 | 46 | 15 |
| Net Income Continuous | -85,403 | -276,126 | -228,302 | -340,141 | -306,620 |
| Net Income | $-85,403 | $-276,126 | $-228,302 | $-340,141 | $-306,620 |
| EPS Basic Total Ops | -11.41 | -65.19 | -56.00 | -90.75 | -103.75 |
| EPS Basic Continuous Ops | -11.41 | -65.19 | -55.96 | -90.78 | -103.63 |
| EPS Diluted Total Ops | -11.41 | -65.19 | -56.00 | -90.75 | -103.75 |
| EPS Diluted Continuous Ops | -11.41 | -65.19 | -55.96 | -90.78 | -103.63 |
| EPS Diluted Before Non-Recurring Items | -11.41 | -65.25 | -68.25 | -90.75 | -103.75 |
| EBITDA(a) | $-78,627 | $-270,385 | $-273,836 | $-329,348 | $-299,892 |